{name}
{subtitle}
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
city
Nearby (River Forest, Illinois, +233 more cities)
facility
West Suburban Medical Center
drug
degarelix, +4 more drugs
drug type
hormone therapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
Nearby (Melrose Park, Illinois, +825 more cities)
facility
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
Nearby (Melrose Park, Illinois, +327 more cities)
facility
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types
Comparing the New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
city
Nearby (Melrose Park, Illinois, +215 more cities)
facility
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
drug
eribulin, +1 more drug
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
Nearby (River Forest, Illinois, +822 more cities)
facility
West Suburban Medical Center
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs